Pharma Foods International Co., Ltd. (TYO:2929)
691.00
-1.00 (-0.14%)
Sep 14, 2026, 3:30 PM JST
TYO:2929 Revenue
In the fiscal year ending July 31, 2026, Pharma Foods International had annual revenue of 63.22B JPY, down -3.12%. Pharma Foods International had revenue of 14.67B in the quarter ending July 31, 2026, a decrease of -20.47%.
Revenue
63.22B
Revenue Growth
-3.12%
P/S Ratio
0.32
Revenue / Employee
103.14M
Employees
613
Market Cap
20.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2026 | 63.22B | -2.04B | -3.12% |
| Jul 31, 2025 | 65.26B | 3.11B | 5.01% |
| Jul 31, 2024 | 62.15B | -6.43B | -9.37% |
| Jul 31, 2023 | 68.57B | 8.39B | 13.94% |
| Jul 31, 2022 | 60.19B | 13.43B | 28.73% |
| Jul 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KYORIN Pharmaceutical | 125.68B |
| ASKA Pharmaceutical Holdings | 70.87B |
| Fuso Pharmaceutical Industries,Ltd. | 62.85B |
| Fuji Pharma | 60.11B |
| Daito Pharmaceutical | 50.65B |
| Koa Shoji Holdings | 24.68B |
| Morishita Jintan | 12.82B |
| Mizuho Medy | 10.82B |